Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Effects of Pelleting, Irradiation, and Autoclaving of Rodent Feed on MPV and MNV Infectivity.

Adams SC, Myles MH, Tracey LN, Livingston RS, Schultz CL, Reuter JD, Leblanc M.

J Am Assoc Lab Anim Sci. 2019 Aug 7. doi: 10.30802/AALAS-JAALAS-18-000142. [Epub ahead of print]

PMID:
31391143
2.

Standardized measurement of breathlessness during exercise.

Lewthwaite H, Koch EM, Tracey L, Jensen D.

Curr Opin Support Palliat Care. 2019 Sep;13(3):152-160. doi: 10.1097/SPC.0000000000000443.

PMID:
31268873
3.

Off to a Bad Start: Cancer Initiation by Pluripotency Regulator PRDM14.

Tracey LJ, Justice MJ.

Trends Genet. 2019 Jul;35(7):489-500. doi: 10.1016/j.tig.2019.04.004. Epub 2019 May 23. Review.

PMID:
31130394
4.

The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.

Tracey LJ, Brooke-Bisschop T, Jansen PWTC, Campos EI, Vermeulen M, Justice MJ.

Mol Cancer Res. 2019 Jul;17(7):1468-1479. doi: 10.1158/1541-7786.MCR-18-1327. Epub 2019 Apr 23.

PMID:
31015254
5.

Meeting report: 32nd international mammalian genome conference.

Moskowitz J, Tracey L, Widmayer S, Dumont B.

Mamm Genome. 2019 Apr;30(3-4):43-53. doi: 10.1007/s00335-019-09797-1. Epub 2019 Apr 1.

PMID:
30937535
6.

Enhancing Social-Emotional Health and Wellbeing in the Early Years (E-SEE): a study protocol of a community-based randomised controlled trial with process and economic evaluations of the incredible years infant and toddler parenting programmes, delivered in a proportionate universal model.

Bywater T, Berry V, Blower SL, Cohen J, Gridley N, Kiernan K, Mandefield L, Mason-Jones A, McGilloway S, McKendrick K, Pickett K, Richardson G, Teare MD, Tracey L, Walker S, Whittaker K, Wright J.

BMJ Open. 2018 Dec 19;8(12):e026906. doi: 10.1136/bmjopen-2018-026906.

7.

Trends in seasonal influenza vaccine uptake during pregnancy in Western Australia: Implications for midwives.

Regan AK, Mak DB, Hauck YL, Gibbs R, Tracey L, Effler PV.

Women Birth. 2016 Oct;29(5):423-429. doi: 10.1016/j.wombi.2016.01.009. Epub 2016 Feb 12.

PMID:
26879102
8.

PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL.

Carofino BL, Ayanga B, Tracey LJ, Brooke-Bisschop T, Justice MJ.

Biol Open. 2016 May 15;5(5):645-53. doi: 10.1242/bio.017699.

9.

A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy.

Regan AK, Tracey LE, Blyth CC, Richmond PC, Effler PV.

Vaccine. 2016 Apr 29;34(20):2299-304. doi: 10.1016/j.vaccine.2016.03.084. Epub 2016 Mar 31.

PMID:
27038132
10.

Surveillance of antenatal influenza vaccination: validity of current systems and recommendations for improvement.

Regan AK, Mak DB, Moore HC, Tracey L, Saker R, Jones C, Effler PV.

BMC Public Health. 2015 Nov 23;15:1155. doi: 10.1186/s12889-015-2234-z.

11.

From the hospital to the home--the rise and rise of Clostridium difficile infection.

Tracey L, Kirke A, Armstrong P, Riley TV.

Aust Fam Physician. 2015 Oct;44(10):712-7. Review.

12.

Post-marketing surveillance of adverse events following immunization with inactivated quadrivalent and trivalent influenza vaccine in health care providers in Western Australia.

Regan AK, Tracey L, Gibbs R.

Vaccine. 2015 Nov 17;33(46):6149-51. doi: 10.1016/j.vaccine.2015.10.005. Epub 2015 Oct 21.

PMID:
26476362
13.

The impact of parental postpartum pertussis vaccination on infection in infants: A population-based study of cocooning in Western Australia.

Carcione D, Regan AK, Tracey L, Mak DB, Gibbs R, Dowse GK, Bulsara M, Effler PV.

Vaccine. 2015 Oct 13;33(42):5654-5661. doi: 10.1016/j.vaccine.2015.08.066. Epub 2015 Aug 29.

PMID:
26320420
14.

Interim estimates of male human papillomavirus vaccination coverage in the school-based program in Australia.

Brotherton JM, Batchelor MR, Bradley MO, Brown SA, Duncombe SM, Meijer D, Tracey LE, Watson M, Webby RJ.

Commun Dis Intell Q Rep. 2015 Jun 30;39(2):E197-200. No abstract available.

15.

Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation.

Regan AK, Blyth CC, Tracey L, Mak DB, Richmond PC, Effler PV.

Vaccine. 2015 Jul 17;33(31):3689-94. doi: 10.1016/j.vaccine.2015.06.022. Epub 2015 Jun 12.

PMID:
26079616
16.

A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant women.

Regan AK, Tracey L, Blyth CC, Mak DB, Richmond PC, Shellam G, Talbot C, Effler PV.

BMC Pregnancy Childbirth. 2015 Mar 18;15:61. doi: 10.1186/s12884-015-0495-2.

17.

Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012.

Eyre DW, Tracey L, Elliott B, Slimings C, Huntington PG, Stuart RL, Korman TM, Kotsiou G, McCann R, Griffiths D, Fawley WN, Armstrong P, Dingle KE, Walker AS, Peto TE, Crook DW, Wilcox MH, Riley TV.

Euro Surveill. 2015 Mar 12;20(10):21059.

18.

Adverse events following influenza immunization reported by healthcare personnel using active surveillance based on text messages.

Tracey LE, Regan AK, Mak DB, Effler PV.

Infect Control Hosp Epidemiol. 2015 May;36(5):608-10. doi: 10.1017/ice.2015.16. Epub 2015 Feb 5. No abstract available.

PMID:
25652211
19.

EbolaTracks: an automated SMS system for monitoring persons potentially exposed to Ebola virus disease.

Tracey LE, Regan AK, Armstrong PK, Dowse GK, Effler PV.

Euro Surveill. 2015 Jan 8;20(1). pii: 20999.

20.

In situ biaxial rotation at low-temperatures in high magnetic fields.

Selby NS, Crawford M, Tracy L, Reno JL, Pan W.

Rev Sci Instrum. 2014 Sep;85(9):095116. doi: 10.1063/1.4896100. Erratum in: Rev Sci Instrum. 2014 Oct;85(10):109903. Tracey, L [corrected to Tracy, L].

PMID:
25273781
21.

Propionibacterium acidipropionici P169 and glucogenic precursors improve rumen fermentation of low-quality forage in beef cattle.

Sanchez PH, Tracey LN, Browne-Silva J, Lodge-Ivey SL.

J Anim Sci. 2014 Apr;92(4):1738-46. doi: 10.2527/jas.2013-7148. Epub 2014 Feb 10.

PMID:
24663167
22.

Increasing incidence of Clostridium difficile infection, Australia, 2011-2012.

Slimings C, Armstrong P, Beckingham WD, Bull AL, Hall L, Kennedy KJ, Marquess J, McCann R, Menzies A, Mitchell BG, Richards MJ, Smollen PC, Tracey L, Wilkinson IJ, Wilson FL, Worth LJ, Riley TV.

Med J Aust. 2014 Mar 17;200(5):272-6.

PMID:
24641152
23.

Ruminant Nutrition Symposium: The utility of lipid extracted algae as a protein source in forage or starch-based ruminant diets.

Lodge-Ivey SL, Tracey LN, Salazar A.

J Anim Sci. 2014 Apr;92(4):1331-42. doi: 10.2527/jas.2013-7027. Epub 2013 Nov 15.

PMID:
24243898
24.

Real-time subglottic stenosis imaging using optical coherence tomography in the rabbit.

Lin JL, Yau AY, Boyd J, Hamamoto A, Su E, Tracy L, Heidari AE, Wang AH, Ahuja G, Chen Z, Wong BJ.

JAMA Otolaryngol Head Neck Surg. 2013 May;139(5):502-9. doi: 10.1001/jamaoto.2013.2643. Erratum in: JAMA Otolaryngol Head Neck Surg. 2013 Aug 1;139(8):771. Tracey, Lauren [corrected to Tracy, Lauren].

25.

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome.

Ryan J, Tivnan A, Fay J, Bryan K, Meehan M, Creevey L, Lynch J, Bray IM, O'Meara A, Tracey L, Davidoff AM, Stallings RL.

Br J Cancer. 2012 Sep 4;107(6):967-76. doi: 10.1038/bjc.2012.356. Epub 2012 Aug 14. Erratum in: Br J Cancer. 2012 Sep 25;107(7):1203. Tracey, L [added].

26.

Postdocs: NPA's success.

Tracey L, Sukhai M, Gelhaus SL, Taylor D.

Science. 2012 Jun 29;336(6089):1638. doi: 10.1126/science.336.6089.1638-b. No abstract available.

PMID:
22745398
27.

Assessing interactions for fixed-dose drug combinations in tumor xenograft studies.

Wu J, Tracey L, Davidoff AM.

J Biopharm Stat. 2012;22(3):535-43. doi: 10.1080/10543406.2011.556285.

28.

Analysis of hip and knee arthroplasty surgical site infection data in Western Australia: null effect of stratification by procedure type.

Tracey L, D'Abrera V, McCann R, Peterson A, Armstrong P.

Infect Control Hosp Epidemiol. 2012 Mar;33(3):313-5. doi: 10.1086/664059. No abstract available.

PMID:
22314075
29.

MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma.

Bray I, Tivnan A, Bryan K, Foley NH, Watters KM, Tracey L, Davidoff AM, Stallings RL.

Cancer Lett. 2011 Apr 1;303(1):56-64. doi: 10.1016/j.canlet.2011.01.016.

30.

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.

Tivnan A, Tracey L, Buckley PG, Alcock LC, Davidoff AM, Stallings RL.

BMC Cancer. 2011 Jan 25;11:33. doi: 10.1186/1471-2407-11-33.

31.

MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma.

Tivnan A, Foley NH, Tracey L, Davidoff AM, Stallings RL.

Anticancer Res. 2010 Nov;30(11):4391-5.

32.

Maturation of tumor vasculature by interferon-beta disrupts the vascular niche of glioma stem cells.

Williams RF, Sims TL, Tracey L, Myers AL, Ng CY, Poppleton H, Nathwani AC, Davidoff AM.

Anticancer Res. 2010 Sep;30(9):3301-8.

PMID:
20944101
33.

Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas.

Carcaboso AM, Elmeliegy MA, Shen J, Juel SJ, Zhang ZM, Calabrese C, Tracey L, Waters CM, Stewart CF.

Cancer Res. 2010 Jun 1;70(11):4499-508. doi: 10.1158/0008-5472.CAN-09-4264. Epub 2010 May 11.

34.

IFN-beta restricts tumor growth and sensitizes alveolar rhabdomyosarcoma to ionizing radiation.

Sims TL, McGee M, Williams RF, Myers AL, Tracey L, Hamner JB, Ng C, Wu J, Gaber MW, McCarville B, Nathwani AC, Davidoff AM.

Mol Cancer Ther. 2010 Mar;9(3):761-71. doi: 10.1158/1535-7163.MCT-09-0800. Epub 2010 Mar 2.

35.

NF-kappaB activation mediates resistance to IFN beta in MLL-rearranged acute lymphoblastic leukemia.

Tracey L, Streck CJ, Du Z, Williams RF, Pfeffer LM, Nathwani AC, Davidoff AM.

Leukemia. 2010 Apr;24(4):806-12. doi: 10.1038/leu.2010.2. Epub 2010 Feb 4.

36.

IFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression.

Rosati SF, Williams RF, Nunnally LC, McGee MC, Sims TL, Tracey L, Zhou J, Fan M, Ng CY, Nathwani AC, Stewart CF, Pfeffer LM, Davidoff AM.

Mol Cancer Ther. 2008 Dec;7(12):3852-8. doi: 10.1158/1535-7163.MCT-08-0806. Epub 2008 Dec 3.

37.

Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.

Wozniak MB, Tracey L, Ortiz-Romero PL, Montes S, Alvarez M, Fraga J, Fernández Herrera J, Vidal S, Rodriguez-Peralto JL, Piris MA, Villuendas Deceased R.

Br J Dermatol. 2009 Jan;160(1):92-102. doi: 10.1111/j.1365-2133.2008.08886.x. Epub 2008 Oct 16.

PMID:
18945306
38.

Somatic hypermutation signature in B-cell low-grade lymphomas.

Tracey L, Aggarwal M, García-Cosio M, Villuendas R, Algara P, Sánchez-Beato M, Sánchez-Aguilera A, García JF, Rodríguez A, Camacho FI, Martínez N, Ruiz-Ballesteros E, Mollejo M, Piris MA.

Haematologica. 2008 Aug;93(8):1186-94. doi: 10.3324/haematol.12999. Epub 2008 Jun 12.

39.

Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression.

Pottier N, Cheok MH, Yang W, Assem M, Tracey L, Obenauer JC, Panetta JC, Relling MV, Evans WE.

Hum Mol Genet. 2007 Oct 1;16(19):2261-71. Epub 2007 Jul 5.

PMID:
17616514
40.

A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.

Alonso SR, Tracey L, Ortiz P, Pérez-Gómez B, Palacios J, Pollán M, Linares J, Serrano S, Sáez-Castillo AI, Sánchez L, Pajares R, Sánchez-Aguilera A, Artiga MJ, Piris MA, Rodríguez-Peralto JL.

Cancer Res. 2007 Apr 1;67(7):3450-60.

41.

Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach.

Villuendas R, Steegmann JL, Pollán M, Tracey L, Granda A, Fernández-Ruiz E, Casado LF, Martínez J, Martínez P, Lombardía L, Villalón L, Odriozola J, Piris MA.

Leukemia. 2006 Jun;20(6):1047-54.

PMID:
16598311
42.

Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.

Tracey L, Pérez-Rosado A, Artiga MJ, Camacho FI, Rodríguez A, Martínez N, Ruiz-Ballesteros E, Mollejo M, Martinez B, Cuadros M, Garcia JF, Lawler M, Piris MA.

J Pathol. 2005 Jun;206(2):123-34.

PMID:
15880597
43.

Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma.

Tracey L, Spiteri I, Ortiz P, Lawler M, Piris MA, Villuendas R.

J Interferon Cytokine Res. 2004 Mar;24(3):185-95.

PMID:
15035852
44.

Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study.

Tracey L, Villuendas R, Dotor AM, Spiteri I, Ortiz P, Garcia JF, Peralto JL, Lawler M, Piris MA.

Blood. 2003 Aug 1;102(3):1042-50. Epub 2003 Apr 10.

45.

Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.

Tracey L, Villuendas R, Ortiz P, Dopazo A, Spiteri I, Lombardia L, Rodríguez-Peralto JL, Fernández-Herrera J, Hernández A, Fraga J, Dominguez O, Herrero J, Alonso MA, Dopazo J, Piris MA.

Am J Pathol. 2002 Nov;161(5):1825-37.

46.

Leadership value added profile: a valuable self-improvement tool for leaders.

Tomcik GM, Tracey LK.

PFCA Rev. 1996 Spring:11-4.

PMID:
10159070
47.

Patient-focused care: key principles to restructuring.

Moffitt GK, Daly PB, Tracey L, Galloway M, Tinstman TC.

Hosp Health Serv Adm. 1993 Winter;38(4):509-22.

PMID:
10130610
48.

A framework for the definition and measurement of underutilization.

Restuccia JD, Payne SM, Tracey LV.

Med Care Rev. 1989 Fall;46(3):255-70. Review. No abstract available.

PMID:
10304026
49.

Posthospital convalescence and return to work.

Walsh DC, Connor E, Tracey LV, Goldberg GA, Egdahl RH.

Health Aff (Millwood). 1989 Fall;8(3):76-90. No abstract available.

PMID:
2551807

Supplemental Content

Loading ...
Support Center